Patent ruling on Lilly drug stirs some surprise

Courtesy Newsvine - business  Tue, 08/18/2009 - 13:44

A federal court ruling that invalidated a patent protecting Eli Lilly and Co.'s cancer drug Gemzar surprised at least one analyst covering the company but stirred little reaction from investors in trading Tuesday.


 

Related items

Drugmaker Eli Lilly reports 4Q profit, sales jump
Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc.

Bristol-Myers: Liver cancer drug failed in study
A key experimental liver cancer drug that Bristol-Myers Squibb Co. has been testing did not meet the main goal of a late-stage study.

Court issues restraining order against Eli Lilly
Amylin Pharmaceuticals says a federal court issued an injunction preventing drug development partner Eli Lilly from using the same sales force to sell an Amylin-developed diabetes treatment...

BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
The X5 Stereo Bluetooth Headset is a portable multi-function device utilizing the latest cutting edge technologies allowing you to stream high quality music and make voice calls using a...

Uniden TRU9496 2-Line Corded/Cordless Digital...
With the Uniden TRU9496 5.8 GHz Digital 2-Line Expandable Phone System is the next generation of 5.8 GHz cordless phones. It's a full-featured digital answerer, with a Dialing keypad and a...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com